ATM and infection: This combination therapy demonstrated significant synergy against XDR pathogens with the potential to improve clinical outcomes in critically ill patients (26, 27).However, Case 4 patient experienced infection relapses twice upon ceasing the treatment when he used 50 mg/kg of CZA plus 30 mg/kg of ATM every 8 h.